MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop

MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.

  • Facebook
  • Twitter
  • Instagram
  • Pinteres

Facebook Twitter Instagram Pinterest
MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop
MedullaX MedullaX

What are You Looking for?

  • Clinical AI & Diagnostics
  • Digital Health & Interoperability
  • Government & Funding
  • NHS & Policy
  • Regulation & Safety
  • Research & Evidence
  • UK HealthTech & Deals
  • Workforce
Home research

research

23 posts
ByMedullax
February 16, 2026

Virtual Reality for Chronic Low Back Pain: A Randomised Trial Explores Efficacy

  • Clinical AI & Diagnostics
ByMedullax
February 16, 2026

AI Model Predicts CKD Progression in Type 2 Diabetes Across Diverse Groups

  • Clinical AI & Diagnostics
ByMedullax
February 9, 2026

AI Predicts Cardiac Activation for Resynchronization Therapy Planning

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

Wearable EEG Devices: Potential for Mild Cognitive Impairment Detection

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

Non-Contrast CT May Offer New Way to Quantify Adipose Tissue Activity

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

AI Method Links CXR Evidence to CT Quantification for ILD Diagnosis

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus)

  • Government & Funding
  • Research & Evidence
ByMedullax
February 7, 2026

AI Model Predicts Intracranial Aneurysm Hemodynamics in Real Time

  • Clinical AI & Diagnostics
ByMedullax
February 2, 2026

Speech-based digital biomarkers: A new frontier for cognitive impairment assessment

  • Clinical AI & Diagnostics
ByMedullax
February 1, 2026

New initiative aims to boost rare cancer patient access to breakthrough trials

  • Government & Funding
MedullaX MedullaX
MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • AI Content Disclaimer
  • Editorial Policy
  • Corrections / Feedback Policy
  • Medical Disclaimer
Facebook Twitter Instagram Pinterest
©️ 2026 — MedullaX. All Rights Reserved.